Terrie Curran

(Ms. Terrie Curran)

Currently holds positions in Myovant Sciences Ltd and Celgene Corp

Positions

Position Company Period
Independent Director Myovant Sciences Ltd Nov. 15, 2016 -
President, Global Inflammation & Immunology Franchise Celgene Corp April 1, 2017 -
Terrie Curran's trades of Arcutis Biotherapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-23 2025-01-21 PS Planned sale
19,109 -5.0%
6.59
USD 125,884
19,109 -5.0% 6.59 USD 125,884
2024-11-13 2024-11-11 S Sale
8,687 -46.1%
10.85
USD 94,238
8,687 -46.1% 10.85 USD 94,238
2024-07-17 2024-07-15 PS Planned sale
33,848 -8.2%
11.72
USD 396,699
33,848 -8.2% 11.72 USD 396,699
2024-03-26 2024-03-22 PS Planned sale
16,851 -3.9%
9.11
USD 153,513
16,851 -3.9% 9.11 USD 153,513
2023-04-07 2023-04-06 B Purchase
12,919 +7.4%
7.82
USD 101,025
12,919 +7.4% 7.82 USD 101,025
2023-03-03 2023-03-01 PS Planned sale
1,436 -0.8%
8.54
USD 12,265
1,436 -0.8% 8.54 USD 12,265
2023-01-20 2023-01-20 S Sale
5,821 -3.2%
8.20
USD 47,729
5,821 -3.2% 8.20 USD 47,729
2022-11-23 2022-11-21 S Sale
1,526 -1.8%
9.60
USD 14,650
1,526 -1.8% 9.60 USD 14,650
2022-05-16 2022-05-13 B Purchase
20,500 +46.5%
7.41
USD 151,835
20,500 +46.5% 7.41 USD 151,835
2021-09-13 2021-09-09 PS Planned sale
4,850 -100.0%
25.58
USD 124,063
4,850 -100.0% 25.58 USD 124,063
2021-03-23 2021-03-22 S Sale
1,140 -100.0%
44.08
USD 50,256
1,140 -100.0% 44.08 USD 50,256
2021-03-23 2021-03-22 PS Planned sale
10,373 -90.1%
43.24
USD 448,495
10,373 -90.1% 43.24 USD 448,495
2019-09-19 2019-09-18 S Sale
6,838 -76.0%
98.31
USD 672,244
6,838 -76.0% 98.31 USD 672,244
2019-09-19 2019-09-18 S Sale
4,500 -33.4%
98.20
USD 441,900
4,500 -33.4% 98.20 USD 441,900
// ... existing code ... // ... rest of the file ...